Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study

Astrid Darsonval,Virginie Besson,Claire Cavalin

Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study

2017

Astrid Darsonval
Virginie Besson
Claire Cavalin

Objective This study aimed to assess the cost impact of administering erythropoiesis-stimulating agents once every 4 weeks instead of one to three times a week to treat anaemia in patients undergoing dialysis.

Keywords:

Dialysis
Chronic kidney failure
Erythropoietin
Intensive care medicine
Erythropoiesis
Surgery
Medicine
cost impact
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations